Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

138.83
Delayed Data
As of Jul 29
 -0.77 / -0.55%
Today’s Change
130.45
Today|||52-Week Range
173.00
-6.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash254.0M244.7M210.2M481.8M
 
 
 
 
 
Short Term Investment Cash88.3M-982.0K-27.3M271.7M
 
 
 
 
 
Cash & Short Term Investments334.3M560.5M632.4M920.2M
 
 
 
 
 
 
ReceivablesReceivables116.0M126.2M163.5M262.3M
 
 
 
 
 
 
InventoriesInventories109.8M110.5M118.7M123.0M
 
 
 
 
 
 
Current AssetsPrepaid Expenses93.5M8.0M7.9M8.0M
 
 
 
 
 
Other Current Assets71.0K104.6M128.8M200.4M
 
 
 
 
 
Current Assets653.7M909.8M1.1B1.5B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross349.8M356.1M364.6M369.6M
 
 
 
 
 
Depreciation-199.1M-210.8M-213.2M-216.5M
 
 
 
 
 
Intangible Assets25.6M22.9M23.9M20.4M
 
 
 
 
 
Other Assets42.7M44.3M76.7M66.7M
 
 
 
 
 
Total Assets856.4M1.1B1.3B1.7B
 
 
 
 
 
 
LiabilitiesAccounts Payable23.0M19.4M20.8M19.5M
 
 
 
 
 
Short Term Debt11.0M11.3M12.0M912.0K
 
 
 
 
 
Accrued Expenses7.1M7.7M9.7M17.0M
 
 
 
 
 
Other Current Liabilities80.6M124.8M173.6M195.7M
 
 
 
 
 
Other Liabilities198.9M192.5M253.3M310.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt27.9M17.3M5.9M5.0M
 
 
 
 
 
Deferred Taxes-4.2M-3.6M-3.2M-2.3M
 
 
 
 
 
Other Liabilities1.4M1.3M862.0K785.0K
 
 
 
 
 
Total Liabilities233.5M215.7M263.8M320.4M
 
 
 
 
 
 
EquityMinority Interest-604.0K-664.0K-472.0K-577.0K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity619.0M886.3M1.0B1.4B
 
 
 
 
 
Total Shareholder Equity619.0M886.3M1.0B1.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding44.2M44.8M42.8M42.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.